Details for Patent: 10,189,850

Which drugs does patent 10,189,850 protect, and when does it expire?

Patent 10,189,850 protects COSELA and is included in one NDA.

This patent has fifty-nine patent family members in twenty-four countries.

Summary for Patent: 10,189,850

Patent landscape, scope, and claims:

Title:	CDK inhibitors
Abstract:	Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
Inventor(s):	Tavares; Francis X. (Durham, NC), Strum; Jay C. (Hillsborough, NC)
Assignee:	G1 Therapeutics, Inc. (Research Park Triangle, NC)
Application Number:	15/918,852
Patent Claim Types: see list of patent claims	Composition; Compound; Dosage form;

Drugs Protected by US Patent 10,189,850

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Pharmacosmos	COSELA	trilaciclib dihydrochloride	POWDER;INTRAVENOUS	214200-001	Feb 12, 2021		RX	Yes	Yes			Y

International Family Members for US Patent 10,189,850

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2011323739
Australia	2016204879
Australia	2018202991
Australia	2020203035
Australia	2020203037
Brazil	112013010018